Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing what to include in a retirement plan at 50 is key to success. Prepare a robust financial strategy for your future.
21,538 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
Analyzing octave specialty (osg) earnings calls goes beyond quarterly numbers. This guide breaks down the key metrics...
This piece examines which stocks people actually search for and why those trends matter. Learn how to separate curios...
IonQ stock surged today after the company issued a revenue forecast that beat expectations, sparking a rally in the q...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
With Ford shares pressed lower by EV doubts and recalls, investors are weighing whether a cheap price reflects a dura...
Rezervology and Titl unveil RezeLink, an AI-native platform designed to speed title searches for SoftPro users, boast...
The EV market is shifting quickly, and two growth stocks sit at opposite ends of the spectrum: Tesla and Rivian. This...
Oracle’s 2026 story blends a sharp stock pullback with strong earnings momentum. Learn what’s driving the 18% drop, w...
SoFi's Mastercard collaboration could unlock more than just card revenue. This article explains why the deal might ex...
A major investment manager disclosed a sizable share disposal in a U.S. utility stock through an SEC filing. The move...